Biomerieux Vitek, Inc.: FDA filings under this applicant name

FDA lists 49 510(k) clearances under the applicant name “Biomerieux Vitek, Inc.” (first 1992, latest 1998), plus 1 PMA decision, across 41 product codes in 6 review panels. Median 510(k) review time under this name: 148 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under bioMérieux, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
20120—
20130—
20140—
20150—
20160—
20170—
20180—
20190—
20200—
20210—
20220—
20230—
20240—
20250—
20260—

Top product codes

Product codeDeviceSubmissions510(k) clearances
GJTPlasma, Coagulation Factor Deficient55
LGDEnzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii33
CHPRadioimmunoassay, Estradiol22
LIQEnzyme Linked Immunoabsorbent Assay, Rotavirus22
LQLGram Positive Identification Panel22
CDPRadioimmunoassay, Total Triiodothyronine11
CECRadioimmunoassay, Free Thyroxine11
CFTRadioimmunoassay, Prolactin (Lactogen)11
CGJRadioimmunoassay, Follicle-Stimulating Hormone11
DAPFibrinogen And Fibrin Split Products, Antigen, Antiserum, Control11

Plus 31 more product codes.

Review panels

Most recent Biomerieux Vitek, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K973819VIDAS D-DIMER (DD) ASSAYDAP1998-03-10154
K972895VIDAS ROTAVIRUS (RTV) ASSAYLIQ1997-10-0359
K965092VIDAS ROTAVIRUS ASSAYLIQ1997-05-05137
K964887VIDAS C. DIFFICILE TOXIN A II ASSAYLLH1997-04-08123
K955627VIDAS CHLAMYDIA BLOCKING ASSAYLJC1996-10-07301
K962609GRAM NEGATIVE IDENTIFICATION PLUS CARDLRH1996-08-3058
K962549VIDAS CREATINE KINASE MB ASSAY 30-421JHX1996-08-3063
K952095VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI)LQL1996-03-12313
K955647VIDAS ESTRADIOL II (E2II) ASSAYCHP1996-02-0656
K943812VIDAS LYME SCREEN IILSR1995-06-13312

39 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
N50510PMAVITEK SYSTEMS GENERAL SUSCEPTIBILITY CARD1978-03-02

Recalls

FDA recall records list no recalls under a recalling firm named Biomerieux Vitek, Inc..

13 product recalls in 11 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Biomerieux Inc (5), bioMerieux, Inc. (5), BioMerieux SA (2).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Biomerieux Vitek, Inc. (a text match, not an official crosswalk):

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Biomerieux Vitek, Inc.?

FDA lists 49 510(k) clearances under the applicant name “Biomerieux Vitek, Inc.” (first 1992, latest 1998), plus 1 PMA decision, across 41 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Biomerieux Vitek, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Biomerieux Vitek, Inc. is 148 days.

Which FDA product codes appear under Biomerieux Vitek, Inc.?

The most frequent FDA product codes under this applicant name are GJT (Plasma, Coagulation Factor Deficient, 5); LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii, 3); CHP (Radioimmunoassay, Estradiol, 2).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup